| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/28/2010 | CN1468307B Anti-dual integrin antibodies, compositions, methods and uses |
| 04/28/2010 | CN101698852A Protein or polypeptide with function of CD137L, and gene and application thereof |
| 04/28/2010 | CN101698832A Production of gluten protein monoclonal antibody and application of cell strain thereof |
| 04/28/2010 | CN101698682A Double-functional fusion protein based on antibacterial peptide, preparation method and applicaitoin thereof |
| 04/28/2010 | CN101698676A Recombinant vibrio vulnificus iron uptake regulatory protein and preparation method thereof |
| 04/28/2010 | CN101698675A Recombinant vibrio parahaemolyticus flagellin and preparation method thereof |
| 04/28/2010 | CN101698674A Recombinant vibrio parahaemolyticus outer membrane protein and preparation method thereof |
| 04/27/2010 | USRE41277 protein D is an Ig receptor for human IgD and has an apparent molecular weight of 42,000; protein D can be detected in all of 116 encapsulated and non-encapsulated isolates of H. influenzae studied |
| 04/27/2010 | US7705195 Screening method |
| 04/27/2010 | US7705140 DNAs encoding TNF receptor family members |
| 04/27/2010 | US7705134 immunoglobulins; fibronectins; drug screening |
| 04/27/2010 | US7705132 Stable polypeptide formulations |
| 04/27/2010 | US7705126 Compositions for controlling hair growth |
| 04/27/2010 | US7705123 Fusion protein contains antibody fragment, or Fc fragment; biodrug for use in the treatment and prevention of autoimmune and cancer diseases |
| 04/27/2010 | US7704964 Methods and compounds for the targeting of protein to exosomes |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704945 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18 |
| 04/27/2010 | US7704925 Ligational encoding using building block oligonucleotides |
| 04/27/2010 | US7704715 Polymorphic monooxygenase comprising mutation in heme domain of a secondary structural element and enhanced heat stability; improved peroxide-driven hydroxylation |
| 04/27/2010 | US7704711 Human protein kinases and uses therefor |
| 04/27/2010 | US7704709 Recombinant cytokine protein for use in treatment of leukemia |
| 04/27/2010 | US7704708 Modified mutein having mutation which causes altered steric hindrance, charge repulsion and/or improvement of solubility by changing interfacial hydrophobic residues to less hydrophobic or hydrophilic residues; for use in capture and purification of biomolecules |
| 04/27/2010 | US7704707 Method of producing microbial transglutaminase |
| 04/27/2010 | US7704685 In vivo production of a clostridial neurotoxin light chain peptide |
| 04/27/2010 | US7704513 Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus |
| 04/27/2010 | US7704509 Producing an infectious, self-replicating, recombinant human parainfluenza viral particle for use in developing vaccine or preventative against respiratory tract infections |
| 04/27/2010 | US7704505 preventing a respiratory syncytial virus (RSV) infection which is MAb1129 by administering to a human in need thereof an effective amount of a humanized anti-RSV antibody which contains the one CDR from each variable heavy and variable light chain of at least one murine monoclonal antibody |
| 04/27/2010 | US7704501 Antibodies binding to human ataxin-1-like polypeptide |
| 04/27/2010 | US7704498 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1 |
| 04/27/2010 | US7704497 Molecules with extended half-lives, compositions and uses thereof |
| 04/27/2010 | US7704496 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 04/27/2010 | CA2413857C Pd-l2 molecules: pd-1 ligands and uses therefor |
| 04/27/2010 | CA2400570C Heterologous expression of neisserial proteins |
| 04/27/2010 | CA2374377C Potassium channel kcnq5 |
| 04/27/2010 | CA2372400C Expression and export of interferon-alpha proteins as fc fusion proteins |
| 04/27/2010 | CA2323776C Cytokine receptor common gamma chain like |
| 04/27/2010 | CA2303202C Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins |
| 04/27/2010 | CA2222129C A method for producing influenza hemagglutinin multivalent vaccines |
| 04/27/2010 | CA2192159C Nucleic acid sequences and expression systems for heparinase ii and heparinase iii derived from flavobacterium heparinum |
| 04/27/2010 | CA2179909C Ligand that binds fas antigen |
| 04/22/2010 | WO2010045340A1 Methods of humanizing and affinity-maturing antibodies |
| 04/22/2010 | WO2010044468A1 Construction and crystallization of expression system for rna polymerase pb1-pb2 protein derived from influenza virus |
| 04/22/2010 | WO2010043701A1 Clarification process |
| 04/22/2010 | WO2010043520A1 Hydrophobin solution containing antifoam |
| 04/22/2010 | WO2010043153A1 Fusion protein inhibiting osteoclast formation, preparation method and drug compositions thereof |
| 04/22/2010 | WO2010043073A1 Collagen polypeptide, preparation method and uses thereof |
| 04/22/2010 | WO2009126306A3 Compositions and methods for detecting egfr mutations in cancer |
| 04/22/2010 | US20100100975 Silk proteins |
| 04/22/2010 | US20100099853 Multivalent Antibody Constructs |
| 04/22/2010 | US20100099850 Human cytokine receptor |
| 04/22/2010 | US20100099617 Secreted proteins |
| 04/22/2010 | US20100099615 Pancreatic regenerating protein i in chronic pancreatitis and aging implications for new therapeutic approaches to diabetes |
| 04/22/2010 | US20100099610 Transglutaminase Variants with Improved Specificity |
| 04/22/2010 | US20100099597 Amylase Variants |
| 04/22/2010 | US20100099184 Polynucleotides encoding class ii cytokine receptor-7 |
| 04/22/2010 | US20100099153 Method for producing L-amino acids using bacteria belonging to the genus escherichia |
| 04/22/2010 | US20100099148 Novel Vectors for Production of Antibodies |
| 04/22/2010 | US20100099147 Anti-IGF-1R Antibodies and Uses Thereof |
| 04/22/2010 | US20100099146 Variants of Beta-Glucosidases |
| 04/22/2010 | US20100099145 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 04/22/2010 | US20100099144 Combined use of cell permeable nanog and oct4 for increasing self-renewal and suppressing differentiation of stem cells |
| 04/22/2010 | US20100099143 Enhanced isomerases for use in production of pantothenic acid or 3-hydroxypropionic acid |
| 04/22/2010 | US20100099142 Processing of Peptides and Proteins |
| 04/22/2010 | US20100098804 Amylolytic enzyme variants |
| 04/22/2010 | US20100098729 Novel surface exposed immunoglobulin d-binding protein from foraxella catarrhalis |
| 04/22/2010 | US20100098719 Fusion Proteins Comprising Two or More IgG Binding Domains of Streptococcal Protein G |
| 04/22/2010 | US20100098713 Drug screening; assay for aldehyde dehydrogenase activity; cancer |
| 04/22/2010 | US20100098711 Antagonist antibodies against ephb3 |
| 04/22/2010 | US20100098697 Chlamydia trachomatis antigens |
| 04/22/2010 | US20100098694 Antibodies to cd40 |
| 04/22/2010 | US20100098680 Anti-pathogen treatments |
| 04/22/2010 | US20100098630 Phenazine and Quinoxaline Substituted Amino Acids and Polypeptides |
| 04/22/2010 | CA2740326A1 Hydrophobin solution containing antifoam |
| 04/22/2010 | CA2739692A1 Enhanced performance hydrogen peroxide formulations comprising proteins and surfactants |
| 04/22/2010 | CA2739392A1 Clarification process |
| 04/21/2010 | EP2177620A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/21/2010 | EP2177616A1 Soluble zcytor 11 cytokine receptors |
| 04/21/2010 | EP2177613A1 Recombinant vector capable of increasing secretion of Koji mold protease |
| 04/21/2010 | EP2177607A1 Animal product free media and processes for obtaining a botulinum toxin |
| 04/21/2010 | EP2177606A2 N-deoxyribosyltransferases from lactobacillus, corresponding nucleotide sequences and their applications |
| 04/21/2010 | EP2177535A1 Antibody having inhibitory activity on infection with hepatitis c virus (hcv), and use thereof |
| 04/21/2010 | EP2176419A1 Invention relating to the expression and permanent secretion of canine interleukins |
| 04/21/2010 | EP1716232B1 Acid alpha-glucosidase and fragments thereof |
| 04/21/2010 | EP1354204B2 Hcv antigen/antibody combination assay |
| 04/21/2010 | EP1332217B1 Novel bacterial phytases and method for producing same |
| 04/21/2010 | EP1325113B1 Factor vii glycoforms |
| 04/21/2010 | EP1231930B1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 04/21/2010 | EP1072010B1 Oligonucleotide mediated nucleic acid recombination |
| 04/21/2010 | EP0922102B1 Hepatocyte growth factor receptor agonists and uses thereof |
| 04/21/2010 | CN101696444A Polypeptide extract as well as preparation method and application thereof |
| 04/21/2010 | CN101696417A Method for producing recombined cationic antibacterial peptide by adopting co-expression anionic ligand |
| 04/21/2010 | CN101696243A Human genetic engineering antibody TRD 109 as well as preparation method and application thereof |
| 04/21/2010 | CN101696239A Human oocyte zona pellucida protein multi-epitope chimeric peptide antigen and preparation method thereof |
| 04/21/2010 | CN101696233A Albumin angiotensin converting enzyme inhibition peptide and preparation method thereof |
| 04/20/2010 | US7700755 cytotoxins; host cells; vaccines; histology |
| 04/20/2010 | US7700752 Microorganisms engineered to express both cytochrome P-450 and the ferredoxin or ferrerdoxin-like protein; hypercholesterolemia and hyperlipidemia; host cells |
| 04/20/2010 | US7700749 Nucleic acid and corresponding protein entitled 205P1B5 useful in treatment and detection of cancer |
| 04/20/2010 | US7700748 VMGLOM gene and its mutations causing disorders with a vascular component |
| 04/20/2010 | US7700742 Antibodies to insulin-like growth factor I receptor |
| 04/20/2010 | US7700737 heat shock proteins (Hsp70); metastatic neoplastic diseases, sarcomas, and carcinomas; humanizing, chimeric; monoclonal antibodies, hybridomas; inhibits natural killer cells |